These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6177380)

  • 21. Behavioural activation induced in the rat by substance P infusion into ventral tegmental area: implication of dopaminergic A10 neurones.
    Kelley AE; Stinus L; Iversen SD
    Neurosci Lett; 1979 Mar; 11(3):335-9. PubMed ID: 514544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pressor responses to electrical and chemical stimulation of the rat brain A10 dopaminergic system.
    Cornish JL; van den Buuse M
    Neurosci Lett; 1994 Aug; 176(2):142-6. PubMed ID: 7530350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Substance K, a novel tachykinin injected bilaterally into the ventral tegmental area of rats increases behavioral response.
    Takano Y; Takeda Y; Yamada K; Kamiya H
    Life Sci; 1985 Dec; 37(26):2507-14. PubMed ID: 2417083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The response of non-dopamine neurons in substantia nigra and ventral tegmental area to amphetamine and apomorphine during hypermotility: the striatal influence.
    Olds ME
    Brain Res; 1988 Jun; 452(1-2):237-54. PubMed ID: 3401732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microinjections of Sch-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine.
    Stewart J; Vezina P
    Brain Res; 1989 Aug; 495(2):401-6. PubMed ID: 2670065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurokinin-alpha injected into the ventral tegmental area elicits a dopamine-dependent behavioral activation in the rat.
    Burns LH; Kelley AE
    Pharmacol Biochem Behav; 1988 Oct; 31(2):255-63. PubMed ID: 2469085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Behavioural and biochemical responses following activation of midbrain dopamine pathways by receptor selective neurokinin agonists.
    Elliott PJ; Mason GS; Stephens-Smith M; Hagan RM
    Neuropeptides; 1991 Jun; 19(2):119-26. PubMed ID: 1719444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular effects of spinal cord substance P: studies with a stable receptor agonist.
    Keeler JR; Charlton CG; Helke CJ
    J Pharmacol Exp Ther; 1985 Jun; 233(3):755-60. PubMed ID: 2409270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of methamphetamine on dopamine cells in the substantia nigra pars compacta and the ventral tegmental area.
    Kamata K; Kameyama T
    Jpn J Pharmacol; 1985 Jun; 38(2):231-4. PubMed ID: 4032860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ventral tegmental area: site through which dopamine D2-receptor agonists evoke behavioural and electrocortical sleep in rats.
    Bagetta G; De Sarro G; Priolo E; Nisticò G
    Br J Pharmacol; 1988 Nov; 95(3):860-6. PubMed ID: 2974741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A functional interaction between the mesolimbic dopamine system and vasopressin release in the regulation of blood pressure in conscious rats.
    Cornish JL; Wilks DP; Van den Buuse M
    Neuroscience; 1997 Nov; 81(1):69-78. PubMed ID: 9300402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of typical and atypical neuroleptics on the behavioural consequences of activation by muscimol of mesolimbic and nigro-striatal dopaminergic pathways in the rat.
    Oakley NR; Hayes AG; Sheehan MJ
    Psychopharmacology (Berl); 1991; 105(2):204-8. PubMed ID: 1686655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of the mesolimbic dopamine system in cardiovascular homeostasis. Stimulation of the ventral tegmental area modulates the effect of vasopressin on blood pressure in conscious rats.
    van den Buuse M
    Clin Exp Pharmacol Physiol; 1998 Sep; 25(9):661-8. PubMed ID: 9750953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuronal sites mediating locomotor hyperactivity following central neurokinin agonist administration.
    Elliott PJ; Paris JM; Mitsushio H; Lorens SA
    Pharmacol Biochem Behav; 1990 Oct; 37(2):329-33. PubMed ID: 1706862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavioural effects of substance P through dopaminergic pathways in the brain.
    Iversen SD
    Ciba Found Symp; 1982; (91):307-24. PubMed ID: 6183078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The substance P fragment SP(1-7) stimulates motor behavior and nigral dopamine release.
    Hall ME; Stewart JM
    Pharmacol Biochem Behav; 1992 Jan; 41(1):75-8. PubMed ID: 1371611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. d-Ala-met-enkephalin injection into the ventral tegmental area: effect on investigatory and spontaneous motor behaviour in the rat.
    Cador M; Kelley AE; Le Moal M; Stinus L
    Psychopharmacology (Berl); 1988; 96(3):332-42. PubMed ID: 3146768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reinforcing properties of the substance P C-fragment analog DiMe-C7 in Carassius auratus.
    Mattioli R; Coelho J; Martins A
    Braz J Med Biol Res; 1996 Apr; 29(4):495-9. PubMed ID: 8736114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of ageing on tachykinin function in the basal ganglia.
    Stoessl AJ; Polanski E; Frydryszak H
    Brain Res; 1993 Dec; 632(1-2):21-8. PubMed ID: 7511976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of cardiac baroreflex sensitivity after central dopaminergic stimulation.
    van den Buuse M; Wilks DP; Cornish JL
    Clin Exp Pharmacol Physiol; 1998; 25(7-8):624-6. PubMed ID: 9673440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.